-
1دورية أكاديمية
المؤلفون: Hiroshi ABE, Hiroyuki FUKUDA, Kazuya SAITA, Koichi HYAKUTAKE, Satoshi KAMADA, Takashi MORISHITA, Tooru INOUE, Toshiyasu OGATA
المصدر: Neurologia medico-chirurgica. 2022, 62(1):35
-
2رسالة جامعية
المؤلفون: 呂, 隆徳
المصدر: Journal of Stroke and Cerebrovascular Diseases. 29 1
مصطلحات موضوعية: Modified Ashworth Scale, Spasticity, botulinum toxin A therapy, range of motion, stroke
وصف الملف: application/pdf
Degree: 博士(医学) -- 旭川医科大学
-
3
المؤلفون: Hiroyuki Fukuda, Tooru Inoue, Takashi Morishita, Kazuya Saita, Hiroshi Abe, Toshiyasu Ogata, Koichi Hyakutake, Satoshi Kamada
المصدر: Neurologia medico-chirurgica
مصطلحات موضوعية: single-joint hybrid assistive limb-assisted rehabilitation, Occupational therapy, medicine.medical_specialty, Combination therapy, medicine.medical_treatment, upper limb, Upper Extremity, Physical medicine and rehabilitation, occupational therapy, Paralysis, Humans, Medicine, Spasticity, Botulinum Toxins, Type A, Stroke, Rehabilitation, business.industry, Stroke Rehabilitation, Recovery of Function, Robotics, medicine.disease, stroke, Treatment Outcome, medicine.anatomical_structure, Upper limb, Original Article, Surgery, Neurology (clinical), botulinum toxin A therapy, medicine.symptom, business, Case series
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d1452e31ab9c6070a2a7128ef1ee4faTest
https://doi.org/10.2176/nmc.oa.2020-0408Test -
4دورية أكاديمية
المؤلفون: Hara, Takatoshi, Abo, Masahiro, Hara, Hiroyoshi, Sasaki, Nobuyuki, Yamada, Naoki, Niimi, Masachika, Shimamoto, Yusuke
المصدر: Toxins, 10 (9) (2018)
مصطلحات موضوعية: Aged, Botulinum Toxins, Type A/therapeutic use, Combined Modality Therapy, Female, Humans, Male, Middle Aged, Muscle Spasticity/drug therapy/etiology/rehabilitation, Orthotic Devices, Stroke/complications, botulinum toxin A therapy, rehabilitation, stroke, Human health sciences, Neurology, Sciences de la santé humaine, Neurologie
العلاقة: urn:issn:2072-6651; https://orbi.uliege.be/handle/2268/241335Test; info:hdl:2268/241335; https://orbi.uliege.be/bitstream/2268/241335/1/toxins-10-00349.pdfTest; scopus-id:2-s2.0-85053048481; info:pmid:30200281
الإتاحة: https://doi.org/10.3390/toxins10090349Test
https://orbi.uliege.be/handle/2268/241335Test
https://orbi.uliege.be/bitstream/2268/241335/1/toxins-10-00349.pdfTest -
5دورية أكاديمية
المؤلفون: Takatoshi Hara, Masahiro Abo, Hiroyoshi Hara, Nobuyuki Sasaki, Naoki Yamada, Masachika Niimi, Yusuke Shimamoto
المصدر: Toxins; Volume 10; Issue 9; Pages: 349
مصطلحات موضوعية: botulinum toxin A therapy, stroke, rehabilitation
جغرافية الموضوع: agris
وصف الملف: application/pdf
العلاقة: Bacterial Toxins; https://dx.doi.org/10.3390/toxins10090349Test
-
6دورية أكاديمية
المؤلفون: O. A. Klochkova, A. L. Kurenkov, H. M. Karimova, B. I. Bursagova, L. S. Namazova-Baranova, L. M. Kuzenkova, A. M. Mamedyarov, G. M. Dvoryakovskaya, О. А. Клочкова, А. Л. Куренков, Х. М. Каримова, Б. И. Бурсагова, Л. С. Намазова-Баранова, Л. М. Кузенкова, А. М. Мамедьяров, Г. М. Дворяковская
المصدر: Pediatric pharmacology; Том 12, № 4 (2015); 398-406 ; Педиатрическая фармакология; Том 12, № 4 (2015); 398-406 ; 2500-3089 ; 1727-5776
مصطلحات موضوعية: шкала GMFCS, drooling, botulinum toxin A therapy, sialorrhea, drooling impact scale, GMFCS, ultrasound-guided injections, сиалорея, слюнотечение, ботулинический токсин типа А, ботулинотерапия, Шкала оценки слюнотечения
العلاقة: Bax M., Goldstein M., Rosenbaum P., Leviton A., Paneth N., Dan B., Jacobsson B., Damiano D. Proposed definition and classifi ca tion of cerebral palsy. Dev Med Child Neurol. 2005; 47 (8): 571–576.; Johnson H., Scott A. Saliva Management. In Dysphagia: Foundation, Theory and Practice. Eds. Cichero J. A. Y., Murdoch B. F. Chichester: J Wiley & Sons, Ltd. 2006. 126 р.; Левицкий Г. Н., Алёхин А. В., Сердюк А. В., Моргунова М. С., Коне ва О. Н., Скворцова В. И. Возможности медикаментозной терапии слюнотечения при болезни двигательного нейрона. Журнал неврологии и психиатрии им. C. C. Корсакова. 2005; 105 (3): 19–22.; Blasco P. A., Allaire J. H. Drooling in the developmentally disabled: management practices and recommendations. Consortium on Drooling. Dev Med Child Neurol. 1992; 34 (10): 849–862.; Бер М., Фротшер М. Топический диагноз в неврологии по Петеру Дуусу: анатомия, физиология, клиника. Пер. с англ. Под ред. З. А. Суслиной. 4-е изд. М.: Практическая медицина. 2009. С. 163–164.; Scully C., Limeres J., Gleeson M., Tomas I., Diz P. Drooling. J Oral Pathol Med. 2009; 38 (4): 321–327.; Erasmus C. E., Van Hulst K., Rotteveel L. J., Jongerius P. H., Van Den Hoogen F. J., Roeleveld N., Rotteveel J. J. Drooling in cerebral palsy: hypersalivation or dysfunctional oral motor control? Dev Med Child Neurol. 2009; 51 (6): 454–459.; Tahmassebi J. F., Curzon M. E. The cause of drooling in children with cerebral palsy hypersalivation or swallowing defect? Int J Paediatr Dent. 2003; 13 (2): 106–111.; Dodds W. J. Physiology of swallowing. Dysphagia. 1989; 3: 171–178.; Senner J. E., Logemann J., Zecker S., Gaebler-Spira D. Drooling, saliva production, and swallowing in cerebral palsy. Dev Med Child Neurol. 2004; 46 (12): 801–806.; Tahmassebi J. F., Curzon M. E. Prevalence of drooling in children with cerebral palsy attending special schools. Dev Med Child Neurol. 2003; 45 (9): 613–617.; Parkes J., Hill N., Platt M. J., Donnelly C. Oromotor dysfunction and communication impairments in children with cerebral palsy: a register study. Dev Med Child Neurol. 2010; 52 (12): 1113–1119.; Lin Y. C., Shieh J. Y., Cheng M. L., Yang P. Y. Botulinum toxin type A for control of drooling in Asian patients with cerebral palsy. Neurology. 2008; 70 (4): 316–318.; Lakraj A. A., Moghimi N., Jabbari B. Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins. Toxins (Basel). 2013; 5 (5): 1010–1031.; Fairhurst C. B., Cockerill H. Management of drooling in children. Arch Dis Child Educ. Pract Ed. 2011; 96 (1): 25–30.; Клочкова О. А., Куренков А. Л., Намазова-Баранова Л. С., Мамедъяров А. М. Паттерны спастичности мышц верхних конечностей и применение ботулинотерапии у пациентов с детским церебральным параличом с поражением рук. Педиатрическая фармакология. 2013; 10 (5): 31–39.; Reddihough D., Erasmus C. E., Johnson H., McKellar G. M., Jon gerius P. H. Cereral Palsy Institute. Botulinum toxin assessment, intervention and aftercare for paediatric and adult drooling: international consensus statement. Eur J Neurol. 2010; 17 (Suppl. 2): 109–121.; Naumann M., So Y., Argoff C. E., Childers M. K., Dykstra D. D., Gronseth G. S., Jabbari B., Kaufmann H. C., Schurch B., Silber stein S. D., Simpson D. M. Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008; 70 (19): 1707–1714.; Rodwell K., Edwards P., Ware R. S., Boyd R. Salivary gland botulinum toxin injections for drooling in children with cerebral palsy and neurodevelopmental disability: a systematic review. Dev Med Child Neurol. 2012; 54 (11): 977–987.; Naumann M., Dressler D., Hallett M., Jankovic J., Schiavo G., Segal K. R., Truong D. Evidence based review and assessment of botulinum neurotoxin for the treatment of secretory disorders. Toxicon. 2013; 67: 141–152.; Walshe M., Smith M., Pennington L. Interventions for drooling in children with cerebral palsy. Cochrane Database Syst Rev. 2012; 2: CD008624. Doi:10.1002/14651858.CD008624.pub2.; Носко А. С., Зыков В. П., Комарова И. Б. Коррекция сиалореи в нейропедиатрии. Фокус на препаратах ботулинического токсина типа А как метод первого ряда выбора. Детская и подростковая реабилитация. 2013; 2 (21): 33–38.; Palisano R., Rosenbaum P. L., Walter S., Russell D., Wood E., Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997; 39 (4): 214–223.; Reid S. M., Johnson H. M., Reddihough D. S. The Drooling Impact Scale: a measure of the impact of drooling in children with developmental disabilities. Dev Med Child Neurol. 2010; 52 (2): 23–28.; Reid S. M., Johnstone B. R., Westbury C., Rawicki B., Reddihough D. S. Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders. Dev Med Child Neurol. 2008; 50 (2):123–128.; Banerjee K. J., Glasson C., O’Flaherty S. J. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy. Dev Med Child Neurol. 2006; 48 (11): 883–887.; Savarese R., Diamond M., Elovic E., Millis S. R. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy. Am J Phys Med Rehabil. 2004; 83 (4): 304–311.; Alrefai A. H., Aburahma S. K., Khader Y. S. Treatment of sialorrhea in children with cerebral palsy: a double blind placebo controlled trial. Clin Neurol Neurosurg. 2009; 111 (1): 79–82.; Lagalla G., Millevolte M., Capecci M., Provinciali L., Cera volo M. G. Botulinum toxin type A for drooling in Parkinson’s disease: a double blind, randomized, placebo controlled study. Mov Disord. 2006; 21 (5): 704–707.; Kalf J. G., Smit A. M., Bloem B. R., Zwarts M. J., Mulleners W. M., Munneke M. Botulinum toxin A for drooling in Parkinson’s disease: a pilot study to compare submandibular to parotid gland injections. Parkinsonism Relat Disord. 2007; 13 (8): 532–534.; Jongerius P. H., van den Hoogen F. J., van Limbeek J., Gabreels F. J., van Hulst K., Rotteveel J. J. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial. Pediatrics. 2004; 114 (3): 620–627.; Harris S. R., Purdy A. H. Drooling and its management in cerebral palsy. Dev Med Child Neurol. 1987; 29 (6): 807–811.; Erasmus C. E., Scheffer A. R., van Hulst K., van Limbeek J., van den Hoogen F. J., Rotteveel J. J., Jongerius P. H. Does motor perfor mance matter in botulinum toxin efficacy for drooling? Pediatr Neurol. 2011; 45 (2): 95–99.; https://www.pedpharma.ru/jour/article/view/508Test
الإتاحة: https://doi.org/10.15690/pf.v12i4.1420Test
https://doi.org/10.1002/14651858.CD008624.pub2Test
https://www.pedpharma.ru/jour/article/view/508Test -
7دورية أكاديمية
المؤلفون: Haruyoshi Toyota, Kazutaka Suzuki, Osamu Mimura, Shigeru Kinoshita, Yumiko Nakamura, 三村 治, 中村 由美子, 木下 茂, 豊田 晴義, 鈴木 一隆
المصدر: 神経眼科 / Neuro-Ophthalmology Japan. 2015, 32(3):269
-
8دورية أكاديمية
المؤلفون: Hara, Takatoshi, Abo, Masahiro, Hara, Hiroyoshi, Kobayashi, Kazushige, Shimamoto, Yusuke, Shibata, Yamato, Sasaki, Nobuyuki, Yamada, Naoki, Niimi, Masachika
المصدر: The International journal of neuroscience, 128 (5), 412-420 (2018)
مصطلحات موضوعية: Adult, Aged, Botulinum Toxins, Type A/therapeutic use, Dose-Response Relationship, Drug, Female, Humans, Locomotion/drug effects, Lower Extremity/diagnostic imaging/physiopathology, Male, Middle Aged, Motor Activity/drug effects, Muscle Spasticity/diagnostic imaging/drug therapy/etiology/rehabilitation, Muscle, Skeletal/drug effects, Neuromuscular Agents/therapeutic use, Severity of Illness Index, Stroke/complications, Stroke Rehabilitation, Ultrasonography, Stroke, botulinum toxin A therapy, multidisciplinary rehabilitation, muscle echo intensity, Human health sciences, Neurology, Sciences de la santé humaine, Neurologie
العلاقة: urn:issn:0020-7454; urn:issn:1563-5279; https://orbi.uliege.be/handle/2268/241465Test; info:hdl:2268/241465; scopus-id:2-s2.0-85031921424; info:pmid:28985683
الإتاحة: https://doi.org/10.1080/00207454.2017.1389927Test
https://orbi.uliege.be/handle/2268/241465Test -
9
المصدر: Journal of Stroke and Cerebrovascular Diseases. 29(1):104481
مصطلحات موضوعية: musculoskeletal diseases, body regions, Modified Ashworth Scale, Spasticity, botulinum toxin A therapy, stroke, range of motion
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=jairo_______::d09deb78ab2f2903461b8debc64b3ff3Test
http://amcor.asahikawa-med.ac.jp/modules/xoonips/detail.php?id=20200325_K540Test -
10دورية أكاديمية
المؤلفون: Hara, Takatoshi, Abo, Masahiro, Hara, Hiroyoshi, Kobayashi, Kazushige, Shimamoto, Yusuke, Samizo, Yuta, Sasaki, Nobuyuki, Yamada, Naoki, Niimi, Masachika
المصدر: The International journal of neuroscience, 127 (6), 469-478 (2017)
مصطلحات موضوعية: Aged, Botulinum Toxins, Type A/therapeutic use, Female, Follow-Up Studies, Humans, Lower Extremity/physiopathology, Male, Middle Aged, Muscle Spasticity/drug therapy/rehabilitation, Neuromuscular Agents/therapeutic use, Retrospective Studies, Stroke/complications, Stroke Rehabilitation/methods, Treatment Outcome, Upper Extremity/physiopathology, botulinum toxin A therapy, multidisciplinary rehabilitation, stroke, Human health sciences, Neurology, Sciences de la santé humaine, Neurologie
العلاقة: urn:issn:0020-7454; urn:issn:1563-5279; https://orbi.uliege.be/handle/2268/241462Test; info:hdl:2268/241462; scopus-id:2-s2.0-84976322353; info:pmid:27256591
الإتاحة: https://doi.org/10.1080/00207454.2016.1196204Test
https://orbi.uliege.be/handle/2268/241462Test